Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience-Reference-Cited by-同舟云学术

Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience

Published:2018-02 Issue: Volume:37 Page:80-88
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Houzé de l’Aulnoit A.,Rogoz B.,Pinçon C.,Houzé de l’Aulnoit D.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference43 articles.

1. Survie des personnes atteintes de cancer en France métropolitaine, 1989–2013;Cowppli-Bony,2016

2. Breast cancer survival in France: a relative survival analysis based on 68,449 cases treated in the 20 French comprehensive cancer centers between 1980 and 1999;Arveux;Proc Am Soc Clin Oncol,2003

3. The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancer;Ouyang;Breast Cancer Res Treat,2005

4. Combination chemotherapy as an adjuvant treatment in operable breast cancer;Bonadonna;N Engl J Med,1976

5. Evolution actuelle des techniques chirurgicales dans le traitement des cancers invasifs du sein;Bobin;Bull Cancer,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repurposing and Molecular Insights in the Fight Against Breast Cancer;Biomedical and Pharmacology Journal;2024-06-25

2. Targeted delivery of doxorubicin to tumor cells using engineered circular bivalent aptamer;Journal of Drug Delivery Science and Technology;2022-09

3. A novel targeted co-delivery system for transfer of epirubicin and antimiR-10b into cancer cells through a linear DNA nanostructure consisting of FOXM1 and AS1411 aptamers;Journal of Drug Delivery Science and Technology;2021-06

4. Cancer recurrence times from a branching process model;PLOS Computational Biology;2019-11-21

5. B2 Prognostic Score: External Validation of a Clinical Decision-making Tool for Metastatic Breast Cancer;Clinical Breast Cancer;2019-10